RIPK1-IN-22
Product Specifications
Target
RIP kinase
Related Pathways
NF-κB, Apoptosis
Bioactivity
RIPK1-IN-13 (compound 28) is a selective inhibitor of receptor-interacting serine/threonine-protein kinase 1 (RIPK1), showing a pKi of 7.66 as measured by the ADP-Glo kinase assay. It exhibits inhibitory effects in human leukemia U937 cells with a pIC50 of 7.2.
Molecular Formula
C22H22N4O3S
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042784-100 1x 100 µL
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741041-500 1x 500 µL
TRIM29 (TRIM29/1041), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
